Figure S2. t-SNE plots showing subtype clustering of Luminal A cases in the TCGA cohort according to degree of admixture based on Distance Ratio tertile. Luminal A cases progressively migrate towards other subtype regions, while predominantly co-clustering with Luminal B. The pattern is similar to that observed in METABRIC. (PPTX 93 kb
Oslo2 tumors sorted according to membership of each of seven PARADIGM clusters (columns) with heatma...
Additional file 1: Table 1. Intrinsic subtype defined at primary diagnosis or re-biopsy
Table S1. Impact of Location/Neoadjuvant chemotherapy/Surgery on discordance. Quantifying: Recurrenc...
Figure S1. t-SNE plots for all subtypes in the TCGA cohort, showing: 1) luminal subtypes cluster rel...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Figure S3. Comparison of community classifications from each reconciliation method with intrinsic br...
Abstract Background PAM50 gene profiling assigns each cancer to a single intrinsic subtype. However,...
Six proteins differentially expressed between luminal A samples in COCA cluster 1 versus COCA cluste...
Refined subtype labels and intrinsic probes. The refined breast cancer subtype labels defined for ea...
Figure S5. KaplanâMeier survival analysis based on risk score model system (a) and Luminal subtype...
Figure S4. Silhouette width of each sample and community in breast cancer for each reconciliation me...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Oslo2 tumors sorted according to membership of each of seven PARADIGM clusters (columns) with heatma...
Additional file 1: Table 1. Intrinsic subtype defined at primary diagnosis or re-biopsy
Table S1. Impact of Location/Neoadjuvant chemotherapy/Surgery on discordance. Quantifying: Recurrenc...
Figure S1. t-SNE plots for all subtypes in the TCGA cohort, showing: 1) luminal subtypes cluster rel...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Figure S3. Comparison of community classifications from each reconciliation method with intrinsic br...
Abstract Background PAM50 gene profiling assigns each cancer to a single intrinsic subtype. However,...
Six proteins differentially expressed between luminal A samples in COCA cluster 1 versus COCA cluste...
Refined subtype labels and intrinsic probes. The refined breast cancer subtype labels defined for ea...
Figure S5. KaplanâMeier survival analysis based on risk score model system (a) and Luminal subtype...
Figure S4. Silhouette width of each sample and community in breast cancer for each reconciliation me...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Oslo2 tumors sorted according to membership of each of seven PARADIGM clusters (columns) with heatma...
Additional file 1: Table 1. Intrinsic subtype defined at primary diagnosis or re-biopsy
Table S1. Impact of Location/Neoadjuvant chemotherapy/Surgery on discordance. Quantifying: Recurrenc...